{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:33:41Z","timestamp":1785598421475,"version":"3.56.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/rlu.0000000000001728","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T18:28:37Z","timestamp":1497983317000},"page":"e390-e391","source":"Crossref","is-referenced-by-count":6,"title":["Improved 123I-Ioflupane Binding After Immunotherapy in Anti\u2013NAE Antibody\u2013Positive Hashimoto Encephalopathy That Clinically Mimicked Multiple System Atrophy"],"prefix":"10.1097","volume":"42","author":[{"given":"Juuri","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamiyu","family":"Ogyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryogo","family":"Minamimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousuke","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20210204","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"key":"R2-40-20210204","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio","volume":"33","author":"Tossici-Bolt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-40-20210204","first-page":"893","article-title":"The biomarker and treatment in Hashimoto\u2019s encephalopathy [in Japanese","volume":"71","author":"Kishitani","year":"2013","journal-title":"Nihon Rinsho"},{"key":"R4-40-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J Neurol Sci"},{"key":"R5-40-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","article-title":"High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto\u2019s encephalopathy","volume":"185","author":"Yoneda","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R6-40-20210204","first-page":"13","article-title":"Cerebellar subacute syndrome due to corticosteroid-responsive encephalopathy associated with autoimmune thyroiditis (also called \u201cHashimoto\u2019s encephalopathy\u201d)","volume":"156","author":"Passarella","year":"2005","journal-title":"Clin Ter"},{"key":"R7-40-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper: neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum"},{"key":"R8-40-20210204","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10072-011-0750-x","article-title":"Hashimoto\u2019s encephalopathy presenting with micrographia as a typical feature of parkinsonism","volume":"33","author":"Inoue","year":"2012","journal-title":"Neurol Sci"},{"key":"R9-40-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.54.3.769","article-title":"Hashimoto encephalopathy: a brainstem vasculitis?","volume":"54","author":"Nolte","year":"2000","journal-title":"Neurology"},{"key":"R10-40-20210204","first-page":"1025","article-title":"Clinical features and treatment of Hashimoto encephalopathy [in Japanese]","volume":"68","author":"Maki","year":"2016","journal-title":"Brain Nerve"},{"key":"R11-40-20210204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000358220","article-title":"Pathophysiological decrease in the regional cerebral blood flow in Hashimoto\u2019s encephalopathy: a multiple-case SPECT study","volume":"72","author":"Muramatsu","year":"2014","journal-title":"Eur Neurol"},{"key":"R12-40-20210204","first-page":"116","article-title":"Improvement of cerebral hypoperfusion with levothyroxine therapy in Hashimoto\u2019s encephalopathy demonstrated by (99m)Tc-HMPAO-SPECT","volume":"2","author":"Schnedl","year":"2013","journal-title":"Eur Thyroid J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:23Z","timestamp":1620973163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201708000-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001728","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}